Serum Immunoglobulin G4 levels are elevated in patients with Graves' ophthalmopathy

Clinical Endocrinology

Volumn 83, Issue 6, 2015, Pages 962-967

  Bozkirli, Emre ^a   Bakiner, Okan Sefa ^a   Ersozlu Bozkirli, Emine Duygu ^b   Eksi Haydardedeoglu, Filiz ^a   Sizmaz, Selcuk ^a   Torun, Aysenur Izol ^a   Ertorer, Melek Eda ^a  

^a BASKENT UNIVERSITY   (Turkey)

^b Numune Training and Research Hospital ^*  (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G4; LIOTHYRONINE; THYROTROPIN; THYROXINE; IMMUNOGLOBULIN G;

ADULT; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ENDOCRINE OPHTHALMOPATHY; EXTRAOCULAR MUSCLE; FEMALE; FREE THYROXINE INDEX; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; LIOTHYRONINE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; SMOKING; THYROID FUNCTION; THYROIDECTOMY; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; BLOOD; GRAVES DISEASE;

ADULT; CROSS-SECTIONAL STUDIES; FEMALE; GRAVES DISEASE; GRAVES OPHTHALMOPATHY; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED;

EID: 84920897118     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12671     Document Type: Article

References (35)

1. Hiromatsu, Y., Eguchi, H., Tani, J., et al,. (2014) Graves' ophthalmopathy: epidemiology and natural history. Internal Medicine, 53, 353-360.
2. Bahn, R.S., (2010) Graves' ophthalmopathy. New England Journal of Medicine, 362, 726-738.
3. Prabhakar, B.S., Bahn, R.S., &, Smith, T.J., (2003) Current perspective on the pathogenesis of Graves' disease and ophthalmopathy. Endocrine Reviews, 24, 802-835.
4. Hamano, H., Kawa, S., Horiuchi, A., et al,. (2001) High serum IgG4 concentrations in patients with sclerosing pancreatitis. New England Journal of Medicine, 344, 732-738.
5. Hamano, H., Kawa, S., Ochi, Y., et al,. (2002) Hydronephrosis associated with retroperitoneal fibrosis and sclerosing pancreatitis. Lancet, 359, 1403-1404.
6. Zen, Y., Harada, K., Sasaki, M., et al,. (2004) IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitis-associated sclerosing cholangitis: do they belong to a spectrum of sclerosing pancreatitis? The American Journal of Surgical Pathology, 28, 1193-1203.
7. Kitagawa, S., Zen, Y., Harada, K., et al,. (2005) Abundant IgG4-positive plasma cell infiltration characterizes chronic sclerosing sialadenitis (Küttner's tumor). The American Journal of Surgical Pathology, 29, 783-791.
8. Takeda, S., Haratake, J., Kasai, T., et al,. (2004) IgG4-associated idiopathic tubulointerstitial nephritis complicating autoimmune pancreatitis. Nephrology Dialysis Transplantation, 19, 474-476.
9. Sato, Y., Ohshima, K., Ichimura, K., et al,. (2008) Ocular adnexal IgG4-related disease has uniform clinicopathology. Pathology International, 58, 465-470.
10. Sato, Y., Notohara, K., Kojima, M., et al,. (2010) IgG4-related disease: historical overview and pathology of hematological disorders. Pathology International, 60, 247-258.
11. Komatsu, K., Hamano, H., Ochi, Y., et al,. (2005) High prevalence of hypothyroidism in patients with autoimmune pancreatitis. Digestive Diseases and Sciences, 50, 1052-1057.
12. Li, Y., Zhou, G., Ozaki, T., et al,. (2012) Distinct histopathological features of Hashimoto's thyroiditis with respect to IgG4-related disease. Modern Pathology, 25, 1086-1097.
13. Li, Y., Nishihara, E., Hirokawa, M., et al,. (2010) Distinct clinical, serological, and sonographic characteristics of Hashimoto's thyroiditis based with and without IgG4-positive plasma cells. The Journal of Clinical Endocrinology & Metabolism, 95, 1309-1317.
14. Takeshima, K., Inaba, H., Furukawa, Y., et al,. (2014) Elevated serum Immunglobulin G4 levels in patients with Graves' Disease and their clinical implications. Thyroid, 24, 736-743.
15. Fonte, R., Pirali, B., Caramia, V., et al,. (2011) Graves'-Like Orbitopathy in a patient with chronic autoimmune pancreatitis. Thyroid, 21, 1389-1392.
16. Kubota, T., Motitani, S., &, Terasaki, H., (2011) Ocular adnexal IgG4-related lymphoplasmacytic infiltrative disorder and Graves ophthalmopathy. Archives of Ophthalmology, 129, 818-819.
17. Castillo, F., Garrity, J.A., &, Kravitz, D.J., (2013) Intractable graves ophthalmopathy? JAMA Ophthalmology, 131, 269-270.
18. Tiegs-Heiden, C.A., Eckel, L.J., Hunt, C.H., et al,. (2014) Immunoglobulin G4-related disease of the orbit: imaging features in 27 patients. American Journal of Neuroradiology, 35, 1393-1397.
19. Brunn, J., Block, U., Ruf, G., et al,. (1981) Volumetric analysis of thyroid lobes by real-time ultrasound. Deutsche Medizinische Wochenschrift, 106, 1338-1340.
20. Werner, S.C., (1977) Modification of the classification of the eye changes of Graves' disease: recommendations of the Ad Hoc Committee of the American Thyroid Association. The Journal of Clinical Endocrinology & Metabolism, 44, 203-204.
21. Mourits, M.P., Prummel, M.F., Wiersinga, W.M., et al,. (1997) Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy. Clinical Endocrinology, 47, 9-14.
22. Umehara, H., Okazaki, K., Masaki, Y., et al,. (2012) Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Modern Rheumatology, 22, 21-30.
23. Van der Zee, J.S., &, Aalberse, R.C., (1988) Immunochemical characteristics of IgG4 antibodies. New England and Regional Allergy Proceedings, 9, 31-33.
24. Dahlgren, M., Khosroshahi, A., Nielsen, G.P., et al,. (2010) Riedel's thyroiditis and multifocal fibrosclerosis are part of the IgG4-related systemic disease spectrum. Arthritis Care & Research, 62, 1312-1318.
25. Bartalena, L., Marcocci, C., Bogazzi, F., et al,. (1998) Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy. New England Journal of Medicine, 338, 73-78.
26. Tanda, M.L., Piantanida, E., Liparulo, L., et al,. (2013) Prevalence and natural history of Graves' orbitopathy in a large series of patients with newly diagnosed Graves' hyperthyroidism seen at a single center. The Journal of Clinical Endocrinology & Metabolism, 98, 1443-1449.
27. Bahn, R.S., (2003) Clinical review 157: pathophysiology of Graves' ophthalmopathy: the cycle of disease. The Journal of Clinical Endocrinology & Metabolism, 88, 1939-1946.
28. Smith, T.J., &, Hoa, N., (2004) Immunoglobulins from patients with Graves' disease induce hyaluronan synthesis in their orbital fibroblasts through the self-antigen, insulin-like growth factor-I receptor. The Journal of Clinical Endocrinology & Metabolism, 89, 5076-5080.
29. Kakudo, K., Li, Y., Taniguchi, E., et al,. (2012) IgG4-related disease of the thyroid glands. Endocrine Journal, 59, 273-281.
30. Gerding, M.N., van der Meer, J.W., Broenink, M., et al,. (2000) Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy. Clinical Endocrinology, 52, 267-271.
31. Eckstein, A.K., Plicht, M., Lax, H., et al,. (2004) Clinic results of anti-inflammatory therapy in Graves' ophthalmopathy and association with thyroidal autoantibodies. Clinical Endocrinology, 61, 612-618.
32. Lytton, S.D., Ponto, K.A., Kanitz, M., et al,. (2010) A novel thyroid stimulating immunoglobulin bioassay is a functional indicator of activity and severity of Graves' orbitopathy. The Journal of Clinical Endocrinology & Metabolism, 95, 2123-2131.
33. Tortora, F., Cirillo, M., Ferrara, M., et al,. (2013) Disease activity in Graves' ophthalmopathy: diagnosis with orbital MR imaging and correlation with clinical score. The Neuroradiology Journal, 26, 555-564.
34. Prummel, M.F., &, Wiersinga, W.M., (1993) Smoking and risk of Graves' disease. The Journal of the American Medical Association, 269, 479-482.
35. Bartalena, L., Marcocci, C., Tanda, M.L., et al,. (1998) Cigarette smoking and treatment outcomes in Graves' ophthalmopathy. Annals of Internal Medicine, 129, 632-635.